33,871 Shares in Inspire Medical Systems, Inc. (NYSE:INSP) Acquired by Trexquant Investment LP

Trexquant Investment LP purchased a new stake in shares of Inspire Medical Systems, Inc. (NYSE:INSP) during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 33,871 shares of the company’s stock, valued at approximately $6,279,000. Trexquant Investment LP owned approximately 0.11% of Inspire Medical Systems at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in the company. Mutual of America Capital Management LLC raised its position in shares of Inspire Medical Systems by 1.2% during the 4th quarter. Mutual of America Capital Management LLC now owns 4,540 shares of the company’s stock valued at $842,000 after purchasing an additional 55 shares during the period. Wealth Enhancement Advisory Services LLC raised its holdings in Inspire Medical Systems by 1.0% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 7,879 shares of the company’s stock valued at $1,461,000 after acquiring an additional 79 shares during the period. Xponance Inc. lifted its position in shares of Inspire Medical Systems by 2.2% in the fourth quarter. Xponance Inc. now owns 3,824 shares of the company’s stock valued at $709,000 after acquiring an additional 82 shares in the last quarter. Harbour Investments Inc. boosted its stake in shares of Inspire Medical Systems by 101.0% in the fourth quarter. Harbour Investments Inc. now owns 197 shares of the company’s stock worth $37,000 after acquiring an additional 99 shares during the period. Finally, Nisa Investment Advisors LLC grew its position in shares of Inspire Medical Systems by 37.3% during the fourth quarter. Nisa Investment Advisors LLC now owns 368 shares of the company’s stock worth $68,000 after purchasing an additional 100 shares in the last quarter. Hedge funds and other institutional investors own 94.91% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on the company. Piper Sandler dropped their price target on Inspire Medical Systems from $260.00 to $233.00 and set an “overweight” rating for the company in a research note on Monday, February 10th. Truist Financial cut their target price on shares of Inspire Medical Systems from $250.00 to $235.00 and set a “buy” rating for the company in a research note on Tuesday, February 11th. Stifel Nicolaus decreased their price target on shares of Inspire Medical Systems from $200.00 to $190.00 and set a “hold” rating on the stock in a research note on Tuesday, January 21st. KeyCorp restated an “overweight” rating and set a $234.00 price objective (down previously from $236.00) on shares of Inspire Medical Systems in a research report on Friday, January 24th. Finally, Royal Bank of Canada reiterated an “outperform” rating and issued a $260.00 target price on shares of Inspire Medical Systems in a research report on Tuesday, February 11th. Three research analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $226.70.

Insider Activity

In related news, insider Randy Ban sold 25,584 shares of the business’s stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $183.50, for a total transaction of $4,694,664.00. Following the completion of the transaction, the insider now owns 7,259 shares in the company, valued at $1,332,026.50. The trade was a 77.90 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CTO John Rondoni sold 583 shares of the stock in a transaction on Tuesday, February 11th. The stock was sold at an average price of $170.49, for a total value of $99,395.67. Following the completion of the sale, the chief technology officer now owns 10,424 shares in the company, valued at approximately $1,777,187.76. The trade was a 5.30 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 26,225 shares of company stock valued at $4,806,530. 4.10% of the stock is currently owned by company insiders.

Inspire Medical Systems Trading Down 5.3 %

INSP opened at $141.49 on Friday. Inspire Medical Systems, Inc. has a 12 month low of $123.00 and a 12 month high of $257.40. The stock has a 50-day moving average of $175.94 and a 200 day moving average of $188.34. The firm has a market cap of $4.21 billion, a P/E ratio of 81.78, a P/E/G ratio of 2.86 and a beta of 1.39.

Inspire Medical Systems (NYSE:INSP) last released its earnings results on Monday, February 10th. The company reported $1.15 earnings per share for the quarter, beating the consensus estimate of $0.74 by $0.41. Inspire Medical Systems had a return on equity of 8.19% and a net margin of 6.67%. On average, research analysts forecast that Inspire Medical Systems, Inc. will post 2.16 earnings per share for the current fiscal year.

Inspire Medical Systems Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.